← Back to Search

Device

3D digital scanning for maxillofacial prosthetics for Maxillofacial Abnormalities

N/A
Waitlist Available
Led By Kyle Vankoevering, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial uses a special 3D scanner to take detailed pictures of patients' heads and faces to create custom-fit prostheses. It aims to make the process faster and more efficient while maintaining quality. The target group is patients who need head and face prostheses.

Eligible Conditions
  • Maxillofacial Abnormalities
  • Craniofacial Anomaly
  • Facial deformities
  • Craniofacial Dysmorphism
  • Prosthetic Treatment

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of hours spent to create the prosthetic
Time the participants spend in the clinic
Secondary study objectives
Number of adverse events related to the prosthetic
Quality of life measures by modified Toronto Outcome Measure of Craniofacial Prosthetics (TOMCP) for extraoral prosthesis.
Prosthesis
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 3D digital scanning for maxillofacial prostheticsExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,853 Previous Clinical Trials
6,433,025 Total Patients Enrolled
Kyle Vankoevering, MDPrincipal InvestigatorUniversity of Michigan
David Zopf, MDPrincipal Investigator - University of Michigan
University of Michigan Hospital, Von Voigtlander Women's Hospital
1 Previous Clinical Trials
40 Total Patients Enrolled
~0 spots leftby Nov 2025